US$ 28.32
semaglutide weight loss medication GLP-1 Options Wegovy® | Wegovy Weight Loss
Description
We are cash-based for this track

Novo Nordisk's oral version of its obesity injection Wegovy could enter the market by year-end, while Eli Lilly's pill orforglipron could launch next year

Orforglipron, developed by Lilly, is also a type of GLP-1 agonist, but its a smaller molecule that doesnt need to be digested by your stomach

Austin K, Imam NA, Pintar JE, Brubaker PL
Chemical & Engineering News, 2026
